During the past decade, CRU Hungary Kft. conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 7 clinical trials were completed. i.e. 350% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CRU Hungary Kft." #1 sponsor was "Pfizer" with 5 trials, followed by "Celgene" with 3 trials sponsored, "Amgen" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Incyte Corporation" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CRU Hungary Kft." #1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "CRU Hungary Kft." are "Crohn Disease" (3 trials), "Atopic Dermatitis" (2 trials), "Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors" (1 trials), "B-Cell Non-Hodgkin Lymphoma (NHL)" (1 trials) and "Chronic Kidney Disease (CKD)" (1 trials). Many other conditions were trialed in "CRU Hungary Kft." in a lesser frequency.

Most popular intervention types in "CRU Hungary Kft." are "Drug" (16 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Ozanimod" (3 trials), "Avelumab Phase 1b" (1 trials), "Avelumab Phase 2" (1 trials) and "CP-690,550" (1 trials). Other intervention names were less common.

The vast majority of trials in "CRU Hungary Kft." are 17 trials for "All" genders.

Currently, there are NaN active trials in "CRU Hungary Kft.". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in CRU Hungary Kft., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in CRU Hungary Kft., 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".